MSB 2.17% $1.13 mesoblast limited

Revascor, four years in hibernation as Mesoblast sorted GVHD....

  1. 3,901 Posts.
    lightbulb Created with Sketch. 1330
    Revascor, four years in hibernation as Mesoblast sorted GVHD. Now the giant has snaped back into life.
    We have a meeting with the FDA booked for AA.
    CLBP P 3 trial underway.

    Wait on, " P3 trial underway " Is there a message there from the FDA. Did I see something about how the potancy assay had to be fit for commercial use before a P2 or P3 would be given the go ahead ?

    This is huge, we have a rulling , the FDA considers the Revascor potancy assay good to go. I would bet that the GVHD potancy assay is also good to go as SI stated that lessons from GVHD would be applyed to Revascor.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
$1.13
Change
-0.025(2.17%)
Mkt cap ! $1.284B
Open High Low Value Volume
$1.15 $1.16 $1.11 $7.363M 6.488M

Buyers (Bids)

No. Vol. Price($)
5 94863 $1.13
 

Sellers (Offers)

Price($) Vol. No.
$1.13 5000 2
View Market Depth
Last trade - 16.10pm 26/07/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.